Revision as of 21:29, 16 April 2020 editSPAWaterBottle (talk | contribs)3 editsmNo edit summary← Previous edit | Revision as of 22:34, 16 April 2020 edit undoSPAWaterBottle (talk | contribs)3 editsmNo edit summaryNext edit → | ||
Line 45: | Line 45: | ||
}} | }} | ||
'''Rociverine''' is an ] |
'''Rociverine''' is an ]. | ||
==References== | ==References== |
Revision as of 22:34, 16 April 2020
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
Clinical data | |
---|---|
Other names | (1S)-1-(diethylamino)propan-2-yl 1-hydroxybi(cyclohexane)-2-carboxylate |
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
UNII | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.053.356 |
Chemical and physical data | |
Formula | C20H37NO3 |
Molar mass | 339.51 g/mol g·mol |
(verify) |
Rociverine is an antimuscarinic.
References
Drugs for functional gastrointestinal disorders (A03) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Drugs for functional bowel disorders |
| ||||||||||||
Belladonna and derivatives (antimuscarinics) |
| ||||||||||||
Propulsives |
This drug article relating to the gastrointestinal system is a stub. You can help Misplaced Pages by expanding it. |